CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1a/1b Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03289962
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:37.440657+00:00
Published At: 2025-07-04T00:00:00+00:00
Record Updated At: 2025-07-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Melanoma", "Non-Small Cell Lung Cancer", "Bladder Cancer", "Colorectal Cancer", "Triple Negative Breast Cancer", "Renal Cancer", "Head and Neck Cancer", "Other Solid Cancers"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-04"
protocolSection.identificationModule.nctId: "NCT03289962"
protocolSection.identificationModule.officialTitle: "A Phase 1a/1b Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Tumors"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.